Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep;26(9):2243-2246.
doi: 10.3201/eid2609.200749.

Mycobacterial Testing Trends, United States, 2009-20151

Samantha G Dean, Emily E Ricotta, Jonathan Fintzi, Yi Ling Lai, Sameer S Kadri, Kenneth N Olivier, Adrian Zelazny, D Rebecca Prevots

Mycobacterial Testing Trends, United States, 2009-20151

Samantha G Dean et al. Emerg Infect Dis. 2020 Sep.

Abstract

We studied 31 US healthcare facilities to characterize trends in mycobacterial testing. During 2009-2015, testing for acid-fast bacilli increased 3.2% annually, and prevalence of pathogenic nontuberculous mycobacteria increased 4.5% annually. These increases were highest for subpopulations at high risk of infection, including older women, Asians, and patients with concurrent conditions.

Keywords: NTM; United States; acid-fast bacilli; acid-fast bacilli testing; bacteria; electronic health records; epidemiology; nontuberculous mycobacteria; pulmonary disease; tuberculosis and other mycobacteria.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Annual percentage change in laboratory testing for acid-fast bacilli in 31 facilities, United States, 2009–2015. Red indicates increasing trends; blue indicates decreasing trends. Error bars indicate 95% CI. COPD, chronic obstructive pulmonary disease.
Figure 2
Figure 2
Annual percentage change in identified pathogenic nontuberculous mycobacteria (NTM) in 31 facilities, United States, 2009–2015. Red indicates increasing trends; blue indicates decreasing trends. Error bars indicate 95% CI. COPD, chronic obstructive pulmonary disease.
See this image and copyright information in PMC

References

    1. Adjemian J, Daniel-Wayman S, Ricotta E, Prevots DR. Epidemiology of nontuberculous mycobacteriosis. Semin Respir Crit Care Med. 2018;39:325–35. 10.1055/s-0038-1651491 - DOI - PMC - PubMed
    1. Novosad S, Henkle E, Winthrop KL. The challenge of pulmonary nontuberculous mycobacterial infection. Curr Pulmonol Rep. 2015;4:152–61. 10.1007/s13665-015-0119-3 - DOI - PMC - PubMed
    1. Donohue MJ, Wymer L. Increasing prevalence rate of nontuberculous mycobacteria infections in five states, 2008–2013. Ann Am Thorac Soc. 2016;13:2143–50. 10.1513/AnnalsATS.201605-353OC - DOI - PubMed
    1. Prevots DR, Shaw PA, Strickland D, Jackson LA, Raebel MA, Blosky MA, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182:970–6. 10.1164/rccm.201002-0310OC - DOI - PMC - PubMed
    1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185:881–6. 10.1164/rccm.201111-2016OC - DOI - PMC - PubMed

Publication types